##Promising drug for NASH## Lanifibranor, a first in class pa | Golden pharma

##Promising drug for NASH##

Lanifibranor, a first in class pan-peroximase proliferator-activated receptor agonist has shown promise in the treatment of non-alcoholic steatohepatitis.

Lanifibranor tackles drivers of the disease, most notably the adipose tissue dysfunction, as well as the mechanisms of inflammation and fibrogenesis inside the liver.

Source-medscape

@Ethiomedicalconsultancy
#Join#us#for#more
Medical videos,
Scientific tips,
Medical books,
Medical journals and
Interesting case discussions

@EthioMedicalConsultancy